Adonis, an AI orchestration platform for RCM, has raised $40m in a Series C funding round led by Quadrille Capital, with continued backing from existing investors General Catalyst and Bling Capital.
The raise brings the New York City-based company’s total funding to over $95m since its founding in 2022. The round follows a strong 2025 for the business, in which it recorded more than fourfold revenue growth and net retention exceeding 130%, reflecting growing investor confidence in technology designed to address the structural pressures facing healthcare providers’ revenue operations.
Adonis offers a platform that combines AI intelligence and autonomous agent tools to help healthcare organisations manage the increasingly complex reimbursement landscape. Its technology proactively monitors revenue cycle activity, identifies issues, recommends tailored actions and autonomously moves claims towards resolution — allowing providers to better compete with payers, stabilise income and reduce administrative burdens on staff.
The funding comes at a pivotal moment for the US healthcare industry. Recent policy shifts, including the passage of the One Big Beautiful Bill, have altered Medicaid and ACA subsidies, pushing up the number of uninsured and self-pay patients whilst introducing additional complexity around reimbursement.
With denial rates climbing and payer policies in constant flux, revenue cycle teams face mounting pressure to navigate an environment where shifting rules and evolving patient coverage make securing payment harder than ever.
The company plans to use the fresh capital to accelerate product innovation across its Intelligence, AI Agents and Orchestration platform, deepen its footprint within the health system market, and continue expanding its workforce.
Adonis co-founder and CEO Akash Magoon said, “The pressure on healthcare organizations is only intensifying. This funding signals that investors are backing solutions that address the structural problems holding RCM teams back, including RCM workforce shortages, denials, and underpayments. Our mission has always been to restore sanity to RCM, and this investment allows us to accelerate the technology RCM teams need to solve these challenges autonomously and at scale.”
Copyright © 2026 FinTech Global
